Iodamide
Title: Iodamide
CAS Registry Number: 440-58-4
CAS Name: 3-(Acetylamino)-5-[(acetylamino)methyl]-2,4,6-triiodobenzoic acid
Additional Names: a,5-diacetamido-2,4,6-triiodo-m-toluic acid; 3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid; ametriodinic acid
Manufacturers' Codes: SH-926
Molecular Formula: C12H11I3N2O4
Molecular Weight: 627.94
Percent Composition: C 22.95%, H 1.77%, I 60.63%, N 4.46%, O 10.19%
Literature References: Prepn: Felder, Pitre, FR 1382277 and US 3360436 (1964 and 1967 to Eprova); Felder et al., Helv. Chim. Acta 48, 259 (1965). Pharmacology and toxicology: F. Bonati et al., Arzneim.-Forsch. 15, 222 (1965); Z. B. Zsebök, L. Szlavy, ibid. 17, 1380 (1967); eidem, Int. Z. Klin. Pharmakol. Ther. Toxikol. 3, 157 (1970). Clinical trials: Grothuesmann, Arzneim.-Forsch. 15, 233 (1965). Comprehensive description: D. Pitré, Anal. Profiles Drug Subs. 15, 337-365 (1986).
Properties: Crystals from acetic acid, mp 255-257°. Soly in water: 0.3 g/100 ml (22°).
Melting point: mp 255-257°
 
Derivative Type: N-Methyl-D-glucamine salt
CAS Registry Number: 18656-21-8
Additional Names: Iodamide meglumine
Trademarks: Isteropac E.R. (Bracco); Jodomiron (Bracco); Opacist E.R. (Bracco); Renovue-65 (BMS); Renovue-DIP (BMS); Uromiro (Bracco)
Molecular Formula: C19H28I3N3O9
Molecular Weight: 823.15
Percent Composition: C 27.72%, H 3.43%, I 46.25%, N 5.10%, O 17.49%
Properties: Sparingly sol in methanol, slightly sol in water, ethanol. Practically insol in ether, chloroform. LD50 in mice, rats, rabbits (g/kg): 9.0, 11.4, 13.2 i.v.; in rats, guinea pigs (g/kg): 17.9, 15.0 i.p. (Bonati).
Toxicity data: LD50 in mice, rats, rabbits (g/kg): 9.0, 11.4, 13.2 i.v.; in rats, guinea pigs (g/kg): 17.9, 15.0 i.p. (Bonati)
 
Therap-Cat: Diagnostic aid (radiopaque medium).
Keywords: Diagnostic Aid (Radiopaque Medium).

Others monographs:
Orange BClobenztropineMazipredoneTositumomab
NormetanephrineLethane® 60PinacoloneOil of Orange Flowers
BorazineSempervirine6-Aminonicotinic AcidMethyl Isopropyl Ketone
ChlorobenzeneBarium Sulfate4,4'-SulfinyldianilineHydramethylnon
©2016 DrugLead US FDA&EMEA